Technical parameters of ultrafine cement. حسب Junxia Zhou (14381598)

"…BET and SEM analyses demonstrated that the specific surface area and porosity (most probable pore size) gradually decreased over time. At various ages, mesopores (cumulative pore diameter, median pore diameter) initially increased and then decreased. …"

Technical parameters of PVA fiber. حسب Junxia Zhou (14381598)

"…BET and SEM analyses demonstrated that the specific surface area and porosity (most probable pore size) gradually decreased over time. At various ages, mesopores (cumulative pore diameter, median pore diameter) initially increased and then decreased. …"

Sample preparation and testing flow chart. حسب Junxia Zhou (14381598)

"…BET and SEM analyses demonstrated that the specific surface area and porosity (most probable pore size) gradually decreased over time. At various ages, mesopores (cumulative pore diameter, median pore diameter) initially increased and then decreased. …"

XRD patterns of MUCG at different curing age. حسب Junxia Zhou (14381598)

"…BET and SEM analyses demonstrated that the specific surface area and porosity (most probable pore size) gradually decreased over time. At various ages, mesopores (cumulative pore diameter, median pore diameter) initially increased and then decreased. …"

FTIR spectra of MUCG at different curing age. حسب Junxia Zhou (14381598)

"…BET and SEM analyses demonstrated that the specific surface area and porosity (most probable pore size) gradually decreased over time. At various ages, mesopores (cumulative pore diameter, median pore diameter) initially increased and then decreased. …"

Description of fitting models. حسب Junxia Zhou (14381598)

"…BET and SEM analyses demonstrated that the specific surface area and porosity (most probable pore size) gradually decreased over time. At various ages, mesopores (cumulative pore diameter, median pore diameter) initially increased and then decreased. …"

Mineral composition of UFC, B, and SF. حسب Junxia Zhou (14381598)

"…BET and SEM analyses demonstrated that the specific surface area and porosity (most probable pore size) gradually decreased over time. At various ages, mesopores (cumulative pore diameter, median pore diameter) initially increased and then decreased. …"

Group-level distributions of magnitude-squared coherence (MSC) changes across theta, alpha, beta, and broadband gamma physiological frequency bands. حسب Kara M. Donovan (21445866)

Flowchart of participants in this study. حسب Yubo Teng (21246745)

"…Participants were categorized into quartiles based on UACR levels. Multivariate linear regression models were used to evaluate the association between UACR and cognitive scores. …"

Ranking position of feature importance for each cluster in the post-vaccination period. حسب Jéssica Villar (21453137)

Ranking position of feature importance for each cluster in the pre-vaccination period. حسب Jéssica Villar (21453137)

Package alternatives for deli meat. حسب Monireh Mahmoudi (21989413)

"…<div><p>Consumer food waste remains a significant concern in the United States, where approximately 40% of food goes uneaten, leading to major economic and environmental consequences. …"

The study timeline. حسب Monireh Mahmoudi (21989413)

"…<div><p>Consumer food waste remains a significant concern in the United States, where approximately 40% of food goes uneaten, leading to major economic and environmental consequences. …"

SHAP Values per cluster in the pre-vaccination period show each feature’s importance on COVID-19 mortality. حسب Jéssica Villar (21453137)

SHAP Values per cluster in the post-vaccination period show each feature’s importance on COVID-19 mortality. حسب Jéssica Villar (21453137)

KEGG enrichment pathway chart (bubble chart) (A) mild PTOA group VS severe PTOA group (B) mild PTOA group VS normal group (C) Severe PTOA group VS normal group. حسب Peng-fei Han (694841)

Effect of 1.25% of SCFP on MDR <i>Salmonella</i> serovars reduction at 24h. حسب Elena G. Olson (10649705)

a, Anti-correlation of gene expression between <i>dmdR1</i> and its predicted regulon. Left: Pearson correlation coefficients (PCCs) between <i>dmdR1</i> and all genes with a DmdR1 position weight matrix (PWM) score greater than 15 in their regulatory region. The vertical dashed line marks the refined PWM score threshold of 22.875.... حسب Hannah E. Augustijn (10773096)

"…Left: Pearson correlation coefficients (PCCs) between <i>dmdR1</i> and all genes with a DmdR1 position weight matrix (PWM) score greater than 15 in their regulatory region. The vertical dashed line marks the refined PWM score threshold of 22.875. …"

Summary of study eligibility criteria. حسب Biban Gill (1473337)

"…Considering the high prevalence of BV among African, Caribbean and Black (ACB) women, we conducted a prospective, randomized, open-label phase 1 clinical trial to determine the feasibility, safety and tolerability of administering low-dose estrogen, probiotics or both in combination to improve vaginal health and decrease HIV-1 susceptibility.</p><p>Methods</p><p>ACB women aged 18–49 from the Greater Toronto Area (GTA) were randomized to one of four study arms: intravaginal estradiol (Estring©; 7.5mg/day); a vaginal probiotic (RepHresh™ Pro-B™) administered twice daily; a combination of Estring© and vaginal RepHresh™ Pro-B™ (twice daily); or the Estring© and oral RepHresh™ Pro-B™ (twice daily), for a duration of 30 days. …"

Summary of study participation and feasibility. حسب Biban Gill (1473337)

"…Considering the high prevalence of BV among African, Caribbean and Black (ACB) women, we conducted a prospective, randomized, open-label phase 1 clinical trial to determine the feasibility, safety and tolerability of administering low-dose estrogen, probiotics or both in combination to improve vaginal health and decrease HIV-1 susceptibility.</p><p>Methods</p><p>ACB women aged 18–49 from the Greater Toronto Area (GTA) were randomized to one of four study arms: intravaginal estradiol (Estring©; 7.5mg/day); a vaginal probiotic (RepHresh™ Pro-B™) administered twice daily; a combination of Estring© and vaginal RepHresh™ Pro-B™ (twice daily); or the Estring© and oral RepHresh™ Pro-B™ (twice daily), for a duration of 30 days. …"